The major endocannabinoid anandamide (AEA), which was found at higher concentrations in the plasma of patients with RA than in the plasma of healthy participants, acts centrally as a cannabinoid 1 receptor (CB1) agonist leading to analgesic effects and is also a partial CB2 agonist. The gene discussed is CNR1; the disease is rheumatoid arthritis.